Aclaris Therapeutics Inc. (NASDAQ:ACRS) went up by 8.63% from its latest closing price compared to the recent 1-year high of $25.48. The company’s stock price has collected -4.87% of loss in the last five trading sessions. Press Release reported 17 hours ago that Aclaris Therapeutics to Participate in Upcoming Investor Conferences
Is It Worth Investing in Aclaris Therapeutics Inc. (NASDAQ :ACRS) Right Now?
Plus, the 36-month beta value for ACRS is at 0.66. Opinions of the stock are interesting as 4 analysts out of 4 who provided ratings for Aclaris Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The average price from analysts is $25.00, which is $1.97 above the current price. ACRS currently public float of 42.28M and currently shorts hold a 2.25% ratio of that float. Today, the average trading volume of ACRS was 3.11M shares.
ACRS’s Market Performance
ACRS stocks went down by -4.87% for the week, with a monthly jump of 27.66% and a quarterly performance of 619.69%, while its annual performance rate touched 1488.28%. The volatility ratio for the week stands at 11.56% while the volatility levels for the past 30 days are set at 10.56% for Aclaris Therapeutics Inc.. The simple moving average for the period of the last 20 days is 9.04% for ACRS stocks with a simple moving average of 356.61% for the last 200 days.
ACRS Trading at 81.69% from the 50-Day Moving Average
After a stumble in the market that brought ACRS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.62% of loss for the given period.
Volatility was left at 10.56%, however, over the last 30 days, the volatility rate increased by 11.56%, as shares surge +26.40% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +493.56% upper at present.
During the last 5 trading sessions, ACRS fell by -4.87%, which changed the moving average for the period of 200-days by +1,727.78% in comparison to the 20-day moving average, which settled at $21.36. In addition, Aclaris Therapeutics Inc. saw 255.95% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for ACRS
Current profitability levels for the company are sitting at:
- -2148.83 for the present operating margin
- +4.07 for the gross margin
The net margin for Aclaris Therapeutics Inc. stands at -2686.11. The total capital return value is set at -56.81, while invested capital returns managed to touch -71.29. Equity return is now at value -103.50, with -64.10 for asset returns.
Based on Aclaris Therapeutics Inc. (ACRS), the company’s capital structure generated 6.02 points at debt to equity in total, while total debt to capital is 5.67. Total debt to assets is 4.28, with long-term debt to equity ratio resting at 5.10. Finally, the long-term debt to capital ratio is 4.82.
When we switch over and look at the enterprise to sales, we see a ratio of 1.73, with the company’s debt to enterprise value settled at 0.58. The receivables turnover for the company is 1.52 and the total asset turnover is 0.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.74.